Serveur d'exploration sur les relations entre la France et l'Australie - Analysis (Allemagne)

Index « Auteurs » - entrée « Roberto Sorio »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Roberto Solano < Roberto Sorio < Roberto Takaoka  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 2.
Ident.Authors (with country if any)Title
000124 (2017) Roberto Sorio [Italie] ; Célia Roemer-Becuwe [France] ; Felix Hilpert [Allemagne] ; Emma Gibbs [Australie] ; Yolanda García [Espagne] ; Janne Kaern [Norvège] ; Manon Huizing [Belgique] ; Petronella Witteveen [Pays-Bas] ; Flora Zagouri [Grèce] ; David Coeffic [France] ; Hans-Joachim Lück [Allemagne] ; Antonio González-Martín [Espagne] ; Gunnar Kristensen [Norvège] ; Charles-Briac Levaché [France] ; Chee Khoon Lee [Australie] ; Val Gebski [Australie] ; Eric Pujade-Lauraine [France]Safety and efficacy of single-agent bevacizumab-containing therapy in elderly patients with platinum-resistant recurrent ovarian cancer: Subgroup analysis of the randomised phase III AURELIA trial.
001195 (2014) Martin R. Stockler [Australie] ; Felix Hilpert [Allemagne] ; Michael Friedlander [Australie] ; Madeleine T. King [Australie] ; Lari Wenzel [Canada] ; CHEE KHOON LEE [Australie] ; Florence Joly [France] ; Nikolaus De Gregorio [Allemagne] ; José Angel Arranz [Espagne] ; Mansoor Raza Mirza [Danemark] ; Roberto Sorio [Italie] ; Ulrich Freudensprung [Suisse] ; Vesna Sneller [Australie] ; Gill Hales [Australie] ; Eric Pujade-Lauraine [France]Patient-Reported Outcome Results From the Open-Label Phase III AURELIA Trial Evaluating Bevacizumab-Containing Therapy for Platinum-Resistant Ovarian Cancer

List of associated KwdEn.i

Nombre de
documents
Descripteur
2Adult
2Aged
2Aged, 80 and over
2Antineoplastic Combined Chemotherapy Protocols (adverse effects)
2Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
2Doxorubicin (administration & dosage)
2Doxorubicin (analogs & derivatives)
2Drug Resistance, Neoplasm
2Female
2Humans
2Middle Aged
2Ovarian Neoplasms (drug therapy)
2Paclitaxel (administration & dosage)
2Polyethylene Glycols (administration & dosage)
2Topotecan (administration & dosage)
1Age Factors
1Antiangiogenic agent
1Antibodies, Monoclonal, Humanized (administration & dosage)
1Antibodies, Monoclonal, Humanized (adverse effects)
1Antineoplastic agent
1Bevacizumab
1Bevacizumab (administration & dosage)
1Bevacizumab (adverse effects)
1Cancerology
1Chemotherapy
1Disease-Free Survival
1Doxorubicin (adverse effects)
1Doxorubicin (therapeutic use)
1Drug Administration Schedule
1Evolution
1Human
1Hypertension (chemically induced)
1Hypertension (physiopathology)
1Immunomodulator
1Neoplasm Recurrence, Local (drug therapy)
1Organoplatinum Compounds (pharmacology)
1Ovary cancer
1Paclitaxel (adverse effects)
1Paclitaxel (therapeutic use)
1Patient Selection
1Phase III trial
1Platinum
1Platinum Compounds
1Polyethylene Glycols (adverse effects)
1Polyethylene Glycols (therapeutic use)
1Prognosis
1Self Report
1Topotecan (adverse effects)
1Topotecan (therapeutic use)
1Treatment Outcome
1Treatment resistance
1Vascular endothelium growth factor

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Allemagne/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/Allemagne/Analysis/Author.i -k "Roberto Sorio" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Allemagne/Analysis/Author.i  \
                -Sk "Roberto Sorio" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Allemagne/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Allemagne
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Roberto Sorio
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024